KEDPLASMA USA opens 13th center in the United States
KEDPLASMA USA, a Kedrion Biopharma company, has announced the opening of a new plasma collection center in Gastonia, NC.
Kedrion Biopharma extends its focus on patients by offering Mix2Vial
A needle-free, double-ended, all plastic filter transfer set for use in reconstituting Koate®-DVI
CURhE, Global Alliance for mother and child healthcare
Kedrion among the founding members with a goal of Rh disease eradication
Kedrion Biopharma Expands Immunoglobulin Therapies Portfolio
Gains Commercial Rights in the U.S. to BIVIGAM®, a Recently Approved IGIV Brand
KEDPlasma welcomes donors to its new Augsburg collection center
Plasma collected in Germany is essential to Kedrion Biopharma’s European plasma-derived therapies
Tuscany Italy adopts revolutionary PID testing
Kedrion S.p.A. at Meyer Hospital’s side to promote early diagnosis of primary immunodeficiencies
Humanitarian programme augments access to clotting factors in developing countries
Kedrion helps the WISH project come true: Italian CNS[NM1] and the World Federation of Hemophilia sign agreement in London
Kedrion Continues Global Expansion with Dedication Ceremony at US Facility
Biopharma Company Celebrates with Local Guests and Dignitaries in Melville, New York
Kedrion employees in the US volunteer to help others
Leaving every place we visit a little better than when we arrived: this is Kedrion Cares
Licenses for RhoGAM® and MICRhoGAM® transferred to Kedrion
This is a milestone in consolidating our portfolio of plasma-derived products